Profile http://med.stanford.edu/profiles/Willard_Fee/ Email this page Printer friendly version

Key Documents

NIH Biosketch available Online

Curriculum Vitae available Online

Willard ("Bill") E. Fee, Jr.

Professor, Otolaryngology (Head and Neck Surgery)
Member, Cancer Center

Contact Information

Clinical Offices

Otolaryngology - Head/Neck Surgery 875 Blake Wilbur Dr Clinic B Stanford, CA 94305-5820
Telephone Work (650) 498-6000 Fax (650) 736-7691
Academic Offices

Personal Information
Email wfee@stanford.edu Tel (650) 725-6500
Not for medical emergencies or patient use

Clinical Focus

Cancer > Head and Neck Cancer
Otolaryngology
Head and Neck Tumor Surgery
Nasopharyngeal Cancer
Otolaryngology/Head&Neck
Parotid Gland

Professional Education

Board Certification: Otolaryngology, American Board of Otolaryngology (1974)
UCLA Medical Center (1974) CA
Wadsworth General Hospital - VA (1971) CA
Harbor-UCLA Medical Center (1970) CA
University of Colorado School of Medicine (1969) CO

Community & International Work

University Grants Committee, Hong Kong More »

Web Site Links

http://med.stanford.edu/profiles/ohns/frdActionServlet?choiceId=facProfile&fid=4331

Research Interests

IRX-2 is a biologic product containing multiple ultra low dose cytokines (IL-1 beta. IL:=2,6,8,10,12, TNF- alpha, G-CSF, and GM-CSF) produced from PHA stimulated monoclear cells obtain from normal donors. Cyclophosphamide 300mg/m2 is given IV on day 1, indomethacin 25 mg p.o. tid together with oral zinc and multivitamins are given daily for 3 weeks. 1cc of IRX-2 is given into each upper sternocleidomasatoid muscle for 10 days between days 4 and 15 (not on Saturday and Sunday). Mutivitamin Supplement and Zinc will also be given. Safety and freedom from relapse will be measured for 5 years.

Clinical Trials

Biopsy of human tumors for cancer stem cell characterization: a feasibility study Recruiting
Identification and Characterization of Novel Proteins in Head and Neck Cancer Recruiting
A Phase 2 Clinical Trial of the Effectiveness of IRX-2 in Treating Patients With Operable Head and Neck Cancer No longer recruiting
Cervical Nodal Mets in Squamous Cell Carcinoma of H&N - MRI, FDG-PET, & Histopathologic Correlation No longer recruiting

Publications

Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Hara W, Loo BW, Goffinet DR, Chang SD, Adler JR, Pinto HA, Fee WE, Kaplan MJ, Fischbein NJ, Le QT. Int J Radiat Oncol Biol Phys. 2008; 71 (2): 393-400
Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, Fee WE, Koong A, Goffinet DR, Xing L, Le QT. Head Neck. 2007; 29 (3): 211-20
Quality of life 17 to 20 years after uvulopalatopharyngoplasty. Goh YH, Mark I, Fee WE. Laryngoscope. 2007; 117 (3): 503-6
Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas. Le QT, Taira A, Budenz S, Jo Dorie M, Goffinet DR, Fee WE, Goode R, Bloch D, Koong A, Martin Brown J, Pinto HA. Cancer. 2006; 106 (9): 1940-9
Advanced-staged tonsillar squamous carcinoma: organ preservation versus surgical management of the primary site. Shirazi HA, Sivanandan R, Goode R, Fee WE, Kaplan MJ, Pinto HA, Goffinet DR, Le QT. Head Neck. 2006; 28 (7): 587-94
Great auricular nerve morbidity after nerve sacrifice during parotidectomy. Ryan WR, Fee WE. Arch Otolaryngol Head Neck Surg. 2006; 132 (6): 642-9
Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. Lin HS, Berry GJ, Sun Z, Fee WE. World J Surg Oncol. 2006; 4 62
Positron-emission tomography for surveillance of head and neck cancer. Ryan WR, Fee WE, Le QT, Pinto HA. Laryngoscope. 2005; 115 (4): 645-50
Split-thickness skin graft attachment to bone lacking periosteum. Tran LE, Berry GJ, Fee WE. Arch Otolaryngol Head Neck Surg. 2005; 131 (2): 124-8
Readers' responses to "are 80 hours a week enough to train a surgeon?". Fee WE, MedGenMed. 2005; 7 (4): 43; author reply 44
Functional outcome after total parotidectomy reconstruction. Fee WE, Tran LE. Laryngoscope. 2004; 114 (2): 223-6
Laryngeal embryonal rhabdomyosarcoma: a case of cervical metastases 13 years after treatment and a 25-year review of existing literature. Sivanandan R, Kong CS, Kaplan MJ, Fee WE, Thu-Le Q, Goffinet DR. Arch Otolaryngol Head Neck Surg. 2004; 130 (10): 1217-22
Identification of tyrosine kinases overexpressed in head and neck cancer. Lin HS, Berry GJ, Fee WE, Terris DJ, Sun Z. Arch Otolaryngol Head Neck Surg. 2004; 130 (3): 311-6
Long-term results of 100 consecutive comprehensive neck dissections: implications for selective neck dissections. Sivanandan R, Kaplan MJ, Lee KJ, Lebl D, Pinto H, Le QT, Goffinet DR, Fee WE. Arch Otolaryngol Head Neck Surg. 2004; 130 (12): 1369-73
Evaluation of a patient with a parotid tumor. Fee WE, Tran LE. Arch Otolaryngol Head Neck Surg. 2003; 129 (9): 937-8
Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers. Gibbs IC, Le QT, Shah RD, Terris DJ, Fee WE, Goffinet DR. Int J Radiat Oncol Biol Phys. 2003; 57 (2): 489-94
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Le QT, Tate D, Koong A, Gibbs IC, Chang SD, Adler JR, Pinto HA, Terris DJ, Fee WE, Goffinet DR. Int J Radiat Oncol Biol Phys. 2003; 56 (4): 1046-54
Airway management after maxillectomy: routine tracheostomy is unnecessary. Lin HS, Wang D, Fee WE, Goode RL, Terris DJ. Laryngoscope. 2003; 113 (6): 929-32
The efficacy of corticosteroids in postparotidectomy facial nerve paresis. Lee KJ, Fee WE, Terris DJ. Laryngoscope. 2002; 112 (11): 1958-63
Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up. Fee WE, Moir MS, Choi EC, Goffinet D. Arch Otolaryngol Head Neck Surg. 2002; 128 (3): 280-4
Nasopharyngectomy after failure of 2 courses of radiation therapy. Ibrahim HZ, Moir MS, Fee WW. Arch Otolaryngol Head Neck Surg. 2002; 128 (10): 1196-7
Percutaneous endoscopic gastrostomy: strategies for prevention and management of complications. Lin HS, Ibrahim HZ, Kheng JW, Fee WE, Terris DJ. Laryngoscope. 2001; 111 (10): 1847-52
Lymph node metastasis in maxillary sinus carcinoma. Le QT, Fu KK, Kaplan MJ, Terris DJ, Fee WE, Goffinet DR. Int J Radiat Oncol Biol Phys. 2000; 46 (3): 541-9
Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases. Le QT, Takamiya R, Shu HK, Smitt M, Singer M, Terris DJ, Fee WE, Goffinet DR, Fu KK. Arch Otolaryngol Head Neck Surg. 2000; 126 (11): 1305-12
Dilatational versus standard tracheostomy: a meta-analysis. Cheng E, Fee WE. Ann Otol Rhinol Laryngol. 2000; 109 (9): 803-7
Nasopharyngectomy for recurrent high-grade mucoepidermoid carcinoma after radiation failure. Brown J, Choi EC, Fee WE. Otolaryngol Head Neck Surg. 1999; 120 (4): 564-6
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR. Cancer. 1999; 86 (9): 1700-11
Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control. Tate DJ, Adler JR, Chang SD, Marquez S, Eulau SM, Fee WE, Pinto H, Goffinet DR. Int J Radiat Oncol Biol Phys. 1999; 45 (4): 915-21
Postoperative irradiation of minor salivary gland malignancies of the head and neck. Le QT, Birdwell S, Terris DJ, Gabalski EC, Varghese A, Fee W, Goffinet DR. Radiother Oncol. 1999; 52 (2): 165-71
Surgery in the aging population. Fee WE, Arch Otolaryngol Head Neck Surg. 1999; 125 (12): 1405; discussion 1406-7
Management of the neck in nasopharyngeal carcinoma (NPC). Brown JJ, Fee WE. Otolaryngol Clin North Am. 1998; 31 (5): 785-802
Management of the clinically positive neck in organ preservation for advanced head and neck cancer. Dagum P, Pinto HA, Newman JP, Higgins JP, Terris DJ, Goffinet DR, Fee WE. Am J Surg. 1998; 176 (5): 448-52
Conservation of resources: indications for intensive care monitoring after upper airway surgery on patients with obstructive sleep apnea. Terris DJ, Fincher EF, Hanasono MM, Fee WE, Adachi K. Laryngoscope. 1998; 108 (6): 784-8
Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer. Newman JP, Terris DJ, Pinto HA, Fee WE, Goode RL, Goffinet DR. Ann Otol Rhinol Laryngol. 1997; 106 (2): 117-22
Radiosurgery for skull base malignancies and nasopharyngeal carcinoma. Cmelak AJ, Cox RS, Adler JR, Fee WE, Goffinet DR. Int J Radiat Oncol Biol Phys. 1997; 37 (5): 997-1003
Baroreflex dysfunction after nasopharyngectomy and bilateral carotid isolation. Lee HT, Brown J, Fee WE. Arch Otolaryngol Head Neck Surg. 1997; 123 (4): 434-7
p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy. Pirollo KF, Hao Z, Rait A, Jang YJ, Fee WE, Ryan P, Chiang Y, Chang EH. Oncogene. 1997; 14 (14): 1735-46
Restoration of the G1 checkpoint and the apoptotic pathway mediated by wild-type p53 sensitizes squamous cell carcinoma of the head and neck to radiotherapy. Chang EH, Jang YJ, Hao Z, Murphy G, Rait A, Fee WE, Sussman HH, Ryan P, Chiang Y, Pirollo KF. Arch Otolaryngol Head Neck Surg. 1997; 123 (5): 507-12
Validity of clinic biopsy specimens in classifying histopathologic characteristics of recurrent nasopharyngeal carcinoma. Brown JJ, Berry GJ, Moretto J, Keating WF, Fee WE. Arch Otolaryngol Head Neck Surg. 1997; 123 (9): 950-5
Hypopharyngeal cancer patient care evaluation. Hoffman HT, Karnell LH, Shah JP, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen AM. Laryngoscope. 1997; 107 (8): 1005-17
Patterns of care for cancer of the larynx in the United States. Shah JP, Karnell LH, Hoffman HT, Ariyan S, Brown GS, Fee WE, Glass AG, Goepfert H, Ossoff RH, Fremgen A. Arch Otolaryngol Head Neck Surg. 1997; 123 (5): 475-83
Ciliary neurotrophic factors enhances peripheral nerve regeneration. Newman JP, Verity AN, Hawatmeh S, Fee WE, Terris DJ. Arch Otolaryngol Head Neck Surg. 1996; 122 (4): 399-403
Potential success of near-total laryngectomy despite postoperative radiation therapy. Terris DJ, Fee WE, Goffinet DR. Laryngoscope. 1996; 106 (9 Pt 1): 1152-6
Effect of arginine on growth of squamous cell carcinoma in the C3H/KM mouse. Hester JE, Fee WE. Arch Otolaryngol Head Neck Surg. 1995; 121 (2): 193-6
Iridium-192 interstitial implant and external beam radiation therapy in the management of squamous cell carcinomas of the tonsil and soft palate. Behar RA, Martin PJ, Fee WE, Goffinet DR. Int J Radiat Oncol Biol Phys. 1994; 28 (1): 221-7
Modified facelift incision for parotidectomy. Terris DJ, Tuffo KM, Fee WE. J Laryngol Otol. 1994; 108 (7): 574-8
Current issues in nerve repair. Terris DJ, Fee WE. Arch Otolaryngol Head Neck Surg. 1993; 119 (7): 725-31
Radiosurgery for palliation of base of skull recurrences from head and neck cancers. Kaplan ID, Adler JR, Hicks WL, Fee WE, Goffinet DR. Cancer. 1992; 70 (7): 1980-4
The electrophysiologic and histologic effects of the Argon Beam Coagulator on peripheral nerves. Steiniger JR, Fee WE, Nowels KW, Lusted HS, Wilkinson AH. Laryngoscope. 1992; 102 (11): 1263-7
Long-term survival after surgical resection for recurrent nasopharyngeal cancer after radiotherapy failure. Fee WE, Roberson JB, Goffinet DR. Arch Otolaryngol Head Neck Surg. 1991; 117 (11): 1233-6
Conservation surgery for laryngeal carcinoma. Roberson JB, Fee WE. Ann Acad Med Singapore. 1991; 20 (5): 656-64
Thyroidectomy under local anesthesia. Hochman M, Fee WE. Arch Otolaryngol Head Neck Surg. 1991; 117 (4): 405-7
Head and neck squamous cancers. Jacobs CD, Goffinet DR, Fee WE. Curr Probl Cancer. 1990 Jan-Feb; 14 (1): 1-72
Surgical resection for recurrent nasopharynx cancer. Fee WE, Cancer Treat Res. 1990; 52 55-9
Esophagography and esophagoscopy. Comparison in the examination of patients with head and neck carcinoma. Nino-Murcia M, Vincent ME, Vaughan C, Fee WE, Goode RL, Robbins AH, Zboralske FF. Arch Otolaryngol Head Neck Surg. 1990; 116 (8): 917-9
Nasopharyngeal carcinoma. Fee WE, Curr Opin Oncol. 1990; 2 (3): 585-8
Early reexploration of the parotid wound following parotidectomy. Chaffoo RA, Fee WE. Am J Otolaryngol. 1989 Jan-Feb; 10 (1): 38-41
Surgical management of recurrent nasopharyngeal carcinoma after radiation failure at the primary site. Fee WE, Gilmer PA, Goffinet DR. Laryngoscope. 1988; 98 (11): 1220-6
Postirradiation sarcoma in retinoblastoma. Induction or predisposition? Schwarz MB, Burgess LP, Fee WE, Donaldson SS. Arch Otolaryngol Head Neck Surg. 1988; 114 (6): 640-4
A new design for intraoperative facial nerve monitoring. Metson R, Thornton A, Nadol JB, Fee WE. Otolaryngol Head Neck Surg. 1988; 98 (3): 258-61
Conradi-Hunerman syndrome. Case report. Hochman M, Fee WE. Ann Otol Rhinol Laryngol. 1987 Sep-Oct; 96 (5): 565-8
Unusual pharyngeal lesion causing dysphagia. Obana KK, Fee WE. Ann Otol Rhinol Laryngol. 1987 Sep-Oct; 96 (5): 527-9
Safety of 125iodine and 192iridium implants to the canine carotid artery. Long-term results. Fee WE, Goffinet DR, Fajardo LF, Guthaner D, Handen C. Acta Otolaryngol. 1987 May-Jun; 103 (5-6): 514-8
MacFee incisions: dispelling the myth of cervical flap vascular inadequacy. Daniell CH, Fee WE. Head Neck Surg. 1987 Jan-Feb; 9 (3): 167-71
Reactivity of monoclonal antibody 17.13. with human squamous cell carcinoma and its application to tumor diagnosis. Ranken R, White CF, Gottfried TG, Yonkovich SJ, Blazek BE, Moss MS, Fee WE, Liu YS. Cancer Res. 1987; 47 (21): 5684-90
Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Jacobs C, Goffinet DR, Goffinet L, Kohler M, Fee WE. Cancer. 1987; 60 (6): 1178-83
A monoclonal antibody to squamous cell carcinoma. Ranken R, Kaplan MJ, Silverman S, Gottfried TG, White C, Fee WE, Yonkovich S, Boles R, Liu V. Laryngoscope. 1987; 97 (6): 657-62
Neuro-Trace: a new intraoperative nerve stimulator. Fee WE, Otolaryngol Head Neck Surg. 1986; 94 (4): 529-31
Use of intraoperative 125iodine implants for large tumors attached to the carotid artery. Fee WE, Goffinet DR. Auris Nasus Larynx. 1985; 12 Suppl 2 S107-11
Prevalence of cigarette smoking in Dundee school children in 1964 and 1984. Fee WM, Briscoe C, Crombie IK, Irving JM, Smith WC, Threapleton L, Tunstall-Pedoe HD. Community Med. 1985; 7 (4): 283-8
Iodine 125 suture implants in the management of advanced tumors in the neck attached to the carotid artery. Paryani SB, Goffinet DR, Fee WE, Goode RL, Levine P, Hopp ML. J Clin Oncol. 1985; 3 (6): 809-12
Safety of 125iodine and 192iridium implants to the canine carotid artery: preliminary report. Fee WE, Goffinet DR, Guthaner D, Fajardo LF, Handen C. Laryngoscope. 1985; 95 (3): 317-20
192Ir pharyngoepiglottic fold interstitial implants. The key to successful treatment of base tongue carcinoma by radiation therapy. Goffinet DR, Fee WE, Wells J, Austin-Seymour M, Clarke D, Mariscal JM, Goode RL. Cancer. 1985; 55 (5): 941-8
125I vicryl suture implants as a surgical adjuvant in cancer of the head and neck. Goffinet DR, Martinez A, Fee WE. Int J Radiat Oncol Biol Phys. 1985; 11 (2): 399-402
Transdermal scopolamine in the treatment of acute vertigo. Babin RW, Balkany TJ, Fee WE. Ann Otol Rhinol Laryngol. 1984 Jan-Feb; 93 (1 Pt 1): 25-7
Parotid gland surgery using the Shaw Hemostatic Scalpel. Fee WE, Handen C. Arch Otolaryngol. 1984; 110 (11): 739-41
One day vs. two days of prophylactic antibiotics in patients undergoing major head and neck surgery. Fee WE, Glenn M, Handen C, Hopp ML. Laryngoscope. 1984; 94 (5 Pt 1): 612-4
Hypopharyngeal reconstruction. Fee WE, Arch Otolaryngol. 1984; 110 (6): 384-5
Diagnosis-related groups. 'Only the lead dog sees a change of scenery'. Fee WE, Arch Otolaryngol. 1984; 110 (10): 631-2
Combined surgery and postoperative irradiation in the treatment of cervical lymph nodes. Goffinet DR, Fee WE, Goode RL. Arch Otolaryngol. 1984; 110 (11): 736-8
Upper airway obstruction due to laryngeal coccidioidomycosis in a 5-year-old child. Benitz WE, Bradley JS, Fee WE, Loomis JC. Am J Otolaryngol. 1983 Sep-Oct; 4 (5): 367-70
Alveolar soft part sarcoma of the tongue. King VV, Fee WE. Am J Otolaryngol. 1983 Sep-Oct; 4 (5): 363-6
Intraoperative iodine 125 implants. Their use in large tumors in the neck attached to the carotid artery. Fee WE, Goffinet DR, Paryani S, Goode RL, Levine PA, Hopp ML. Arch Otolaryngol. 1983; 109 (11): 727-30
Intraoperative pterygo-palatine interstitial 125I seed implants. Goffinet DR, Martinez A, Pooler D, Fee W, Levine PA. Int J Radiat Oncol Biol Phys. 1983; 9 (1): 103-6
Evaluation of frozen section in parotid gland surgery. Hillel AD, Fee WE. Arch Otolaryngol. 1983; 109 (4): 230-2
125Iodine implants as an adjuvant to surgery and external beam radiotherapy in the management of locally advanced head and neck cancer. Martinez A, Goffinet DR, Fee W, Goode R, Cox RS. Cancer. 1983; 51 (6): 973-9
Squamous cell carcinoma of the base of the tongue. Riley RW, Fee WE, Goffinet D, Cox R, Goode RL. Otolaryngol Head Neck Surg. 1983; 91 (2): 143-50
Inverting papilloma of the sphenoid sinus. McElveen JT, Fee WE. Otolaryngol Head Neck Surg. 1981 Sep-Oct; 89 (5): 710-2
Use of the Shaw scalpel in head and neck surgery. Fee WE, Otolaryngol Head Neck Surg. 1981 Jul-Aug; 89 (4): 515-9
Planned approach to the management of malignant invasion of the carotid artery. Olcott C, Fee WE, Enzmann DR, Mehigan JT. Am J Surg. 1981; 142 (1): 123-7
Clinical application of nonacoustic middle ear muscle stimulation. Fee WE, Arch Otolaryngol. 1981; 107 (4): 224-6
Unsuspected esophageal foreign bodies in adults with upper airway obstruction. Handler SD, Beaugard ME, Canalis RF, Fee WE. Chest. 1981; 80 (2): 234-7
Squamous cell proliferative lesion of the nasopharynx in a newborn. Stillwater LB, Fee WE. Otolaryngol Head Neck Surg. 1980 May-Jun; 88 (3): 240-7
Reconstructive versatility of the pectoralis major myocutaneous flap. Strelzow VV, Finseth F, Fee WE. Otolaryngol Head Neck Surg. 1980 Jul-Aug; 88 (4): 368-72
Follicular lymphoid hyperplasia of the hard palate simulating lymphoma. Harsany DL, Ross J, Fee WE. Otolaryngol Head Neck Surg. 1980 Jul-Aug; 88 (4): 349-56
Frontal sinus septectomy for chronic unilateral sinusitis. Goode RL, Strelzow V, Fee WE. Otolaryngol Head Neck Surg. 1980 Jan-Feb; 88 (1): 18-21
Metastasis in head and neck cancer, 1979. Cochran JH, Fee WE. Ann Plast Surg. 1980; 4 (5): 405-9
Aminoglycoside ototoxicity in the human. Fee WE, Laryngoscope. 1980; 90 (10 Pt 2 Suppl 24): 1-19
Synovial chondromatosis of the temporomandibular joint. Fee WE, Windhorst P, Wiggins R, Pang L. Otolaryngol Head Neck Surg. 1979 Nov-Dec; 87 (6): 741-8
Angiosarcoma of the head and neck. Cochran JH, Fee WE. Otolaryngol Head Neck Surg. 1979 Jul-Aug; 87 (4): 409-16
Epiglottitis in an immunosuppressed host. Cochran JH, Fee WE, Maze A. West J Med. 1979; 131 (2): 150-2
Squamous cell carcinoma of the soft palate. Fee WE, Schoeppel SL, Rubenstein R, Goffinet DR, Goode RL, Boles R, Tuschman M. Arch Otolaryngol. 1979; 105 (12): 710-8
Effect of prophylactic antibiotics in radical head and neck surgery. Goode RL, Abramson N, Fee WE, Levine P. Laryngoscope. 1979; 89 (4): 601-8
Tracheoesophageal space abscess. Fee WE, Wilson GG. Laryngoscope. 1979; 89 (3): 377-84
Radioactive suture in the treatment of head an neck cancer. Goode RL, Fee W, Goffinet D, Martinez A. Laryngoscope. 1979; 89 (3): 349-54
Cis-platinum chemotherapy in head and neck cancers. Jacobs C, Bertino JR, Goffinet DR, Fee WE, Goode RL. Otolaryngology. 1978 Sep-Oct; 86 (5): ORL-780-3
24-hour infusion of cis-platinum in head and neck cancers. Jacobs C, Bertino JR, Goffinet DR, Fee WE, Goode RL. Cancer. 1978; 42 (5): 2135-40
[Clinical evaluation of the ototoxicity of aminoglycosides. Comparison of tobramycin and gentamycin. Preliminary report] Fee WE, Nouv Presse Med. 1978; 7 (42): 3854-5
Clinical evaluation of aminoglycoside toxicity: tobramycin versus gentamicin, a preliminary report. Fee WE, Vierra V, Lathrop GR. J Antimicrob Chemother. 1978; 4 Suppl A 31-6
Recurrent mixed tumors of the parotid gland--results of surgical therapy. Fee WE, Goffinet DR, Calcaterra TC. Laryngoscope. 1978; 88 (2 Pt 1): 265-73
Temporal arterial ligation in head and neck surgery with absorbable sutures. Fee WE, Okamoto E, Spellman M, Ward PH. Laryngoscope. 1978; 88 (4): 619-31
Thyroid surgery: surgical and metabolic causes of hypocalcemia. Schaefer SD, Fee WE. Arch Otolaryngol. 1978; 104 (5): 263-6
Planned carotid artery resection in head and neck surgery. Fee WE, Steadman MG. Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol. 1977 Sep-Oct; 84 (5): ORL814-5
Permanent tracheostomy: a new surgical technique. Fee WE, Ward PH. Ann Otol Rhinol Laryngol. 1977 Sep-Oct; 86 (5 Pt 1): 635-8
A method of interstitial tonsillo-palatine implants. Goffinet DR, Martinez A, Palos B, Fee W, Bagshaw MA. Int J Radiat Oncol Biol Phys. 1977 Jan-Feb; 2 (1-2): 155-62
Safety of hospital vs home care of infant tracheotomies. Okamoto E, Fee WE, Boles R, Calcaterra TC, Dobie RA, Steadman MG. Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol. 1977 Jan-Feb; 84 (1): 92-9
Rhomboid flap. Gunter JP, Carder HM, Fee WE. Arch Otolaryngol. 1977; 103 (4): 206-11
Complications of orbital floor implants. Canalis RF, Handler SD, Fee WE, Roser SM. Trans Pac Coast Otoophthalmol Soc Annu Meet. 1977; 58 81-8
Composite hyoid sternohyoid muscle grafts in humans. Its use in reconstruction of subglottic stenosis and the anterior tracheal wall. Ward PH, Canalis R, Fee W, Smith G. Arch Otolaryngol. 1977; 103 (9): 531-4
Pathologic quiz case 2. Allergic vasculitis. Schaefer S, Fee WE. Arch Otolaryngol. 1976; 102 (12): 756-8
Rhomboid flap principles and common variations. Fee WE, Gunter JP, Carder HM. Laryngoscope. 1976; 86 (11): 1706-11
Pathologic quiz case 2: neurilemoma. Smith GA, Canalis RF, Fee W. Arch Otolaryngol. 1976; 102 (10): 640-2
Nonacoustic stimulation of the middle ear muscle reflex. Fee WE, Dirks DD, Morgan DE. Ann Otol Rhinol Laryngol. 1975 Jan-Feb; 84 (1 Pt 1): 80-7
Trigeminal neurinomas. Fee WE, Epsy CD, Konrad HR. Laryngoscope. 1975; 85 (2): 371-6
The brow-lift operation. Rafaty FM, Goode RL, Fee WE. Arch Otolaryngol. 1975; 101 (8): 467-8
The long-term prognosis of aseptic meningitis in childhood. Fee WE, Marks MI, Kardash S, Reite M, Seitz C. Dev Med Child Neurol. 1970; 12 (3): 321-9